Novalar Pharmaceuticals' Unattributed VC Round

Novalar Pharmaceuticals raised a round of funding on July 07, 2010.

Novalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the s…

Articles about Novalar Pharmaceuticals' Unattributed VC Round: